Streetbeat News

Stock Prices

ARTL

Artelo Biosciences (NASDAQ:ARTL) reported a Q2 EPS of $(0.75), beating the analyst estimate of $(0.85) by 11.76%. This represents a 33.93% increase in losses compared to $(0.56) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:19 pm

PALI

Palisade Bio (NASDAQ:PALI) reported a Q2 2024 GAAP EPS of $(3.32), missing the analyst consensus estimate of $(3.11) by 6.75%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:18 pm

ACRV

Acrivon Therapeutics (NASDAQ:ACRV) reported a Q2 EPS of $(0.52), beating the analyst consensus estimate of $(0.63) by 17.46%. This represents a 17.46% improvement over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:18 pm

PODC

PodcastOne has projected its FY25 revenue to be between $51 million and $56 million, which is slightly below the estimated $53.54 million.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:16 pm

TOVX

Theriva Biologics (AMEX:TOVX) reported a Q2 EPS of $(0.43), missing the analyst consensus estimate of $(0.19) by 126.32%. This represents a 26.47% increase in losses compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:15 pm

JRSH

Jerash Holdings (US) (NASDAQ:JRSH) reported Q1 earnings per share (EPS) of $(0.11), missing the analyst estimate of $0.08 by 237.5%. However, the company reported sales of $40.94 million, beating the estimate of $39.75 million by 2.98%.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:15 pm

PSFE

Paysafe Ltd (NYSE: PSFE) reported strong Q2 financial results, with adjusted earnings of 59 cents per share and sales of $439.9 million, both beating analyst estimates. The company saw significant growth in its Merchant Solutions and Digital Wallets segments and raised its full-year 2024 revenue guidance.

Portfolio Pulse from Anusuya Lahiri

August 13, 2024 | 12:15 pm

PRSO

Peraso shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results and issued Q3 revenue guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:13 pm

PDSB

PDS Biotechnology (NASDAQ:PDSB) reported a Q2 EPS loss of $(0.23), beating the analyst consensus estimate of $(0.34) by 32.35%. This represents a 37.84% improvement over the $(0.37) loss per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:13 pm

CMG

SBUX

Starbucks shares are trading higher after the company announced that Chipotle CEO and Chairman Brian Niccol has been named as Starbucks' new Chairman and Chief Executive Officer, effective September 9.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 12:13 pm